Navigation Links
Tapestry Pharmaceuticals to Present Data on TPI 287 at the 2007,AACR Annual Meeting

BOULDER, Colo., March 14, 2007 /PRNewswire-FirstCall/ -- Tapestry Pharmaceuticals, Inc. today announced that it will present new data at the 2007 American Association for Cancer Research (AACR) Annual Meeting, April 14-18 in Los Angeles, Calif. Scientists from Tapestry Pharmaceuticals will discuss preclinical data on the Company's lead compound, TPI 287, in a poster presentation entitled, "TPI 287 crosses the blood brain barrier and contributes to antitumor activity in the U251 glioblastoma intracranial tumor model in nude mice." The poster (#1441) will be presented Sunday, April 15, 2007 from 1:00 - 5:00 p.m. at the Experimental and Molecular Therapeutics 8 session.

About TPI 287

TPI 287, a proprietary next generation taxane, is Tapestry's lead clinical compound. This compound was designed to overcome multi-drug resistance in solid tumors that have become resistant to taxane therapy. In preclinical testing, TPI 287 demonstrated the ability to inhibit tumor cell growth in a number of in vitro cell lines and in general, has shown equivalent inhibition of tumors in certain animal xenograft models when tested against standard comparative agents. In some cell lines resistant to taxanes, TPI 287 has demonstrated greater inhibition of tumors in certain animal xenograft models when tested against standard comparative agents. The in vitro activity was seen across multiple cell lines including cell lines known to be sensitive to taxanes and cell lines known to be resistant to taxanes. Taxane sensitive cell lines in which TPI 287 has shown activity include cell lines derived from breast cancer, uterine cancer and non-small cell lung cancer. Taxane resistant cell lines in which TPI 287 shows greater activity include lines derived from breast and colon cancer. In in vivo testing TPI 287 demonstrated greater tumor growth inhibition activity in tumor cell lines with multiple drug resistance, MDR1.

TPI 28
'"/>




Page: 1 2 3 4

Related medicine technology :

1. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
2. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
3. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
4. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
5. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
6. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
7. Pro-Pharmaceuticals Updates Progress of Clinical Trials & Davanat 505 (b)(2) Filings
8. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
9. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
10. Cyclacel Pharmaceuticals Announces Results of Phase II Seliciclib Combination Studies
11. Arisaph Pharmaceuticals Announces Results of its Potent Smart DPP-4 Inhibitor, ARI-2243, at the ADA
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Tapestry Pharmaceuticals Present Data TPI the AACR Annual Meeting
(Date:5/29/2015)... May 29, 2015  Epic Sciences announced today that ... from metastatic castrate resistant prostate cancer patients, at ... for Clinical Oncology. This application expands the investigational ... behind™ platform to characterize circulating tumor cell ... stage patients have heterogeneous clonal CTC populations harboring ...
(Date:5/29/2015)... THOUSAND OAKS, Calif. , May 29, 2015 ... announced pooled data from two pivotal Phase 3, ... novel calcimimetic, for the treatment of secondary hyperparathyroidism ... receiving hemodialysis. Both studies met the primary endpoint, ... the AMG 416 groups achieved a greater than ...
(Date:5/29/2015)... MALVERN, Pa. , May 29, 2015 /PRNewswire-USNewswire/ ... major focus of the Association for the Advancement ... 1995. With support from AAWC,s corporate ... Educational Portal on the AAWC website ... on a wound care pathway with links to ...
Breaking Medicine Technology:Genetic Analysis of Single Circulating Tumor Cells Shows High Intra-patient Heterogeneity 2Genetic Analysis of Single Circulating Tumor Cells Shows High Intra-patient Heterogeneity 3Amgen Presents Pooled Phase 3 AMG 416 Data For The Treatment Of Secondary Hyperparathyroidism In Patients With Chronic Kidney Disease 2Amgen Presents Pooled Phase 3 AMG 416 Data For The Treatment Of Secondary Hyperparathyroidism In Patients With Chronic Kidney Disease 3Amgen Presents Pooled Phase 3 AMG 416 Data For The Treatment Of Secondary Hyperparathyroidism In Patients With Chronic Kidney Disease 4Amgen Presents Pooled Phase 3 AMG 416 Data For The Treatment Of Secondary Hyperparathyroidism In Patients With Chronic Kidney Disease 5Amgen Presents Pooled Phase 3 AMG 416 Data For The Treatment Of Secondary Hyperparathyroidism In Patients With Chronic Kidney Disease 6Amgen Presents Pooled Phase 3 AMG 416 Data For The Treatment Of Secondary Hyperparathyroidism In Patients With Chronic Kidney Disease 7The Association for the Advancement of Wound Care Educates the Public 2
... Hospital one of 18 centers involved in 10-year study, ... study,published in the August 28 issue of the New ... women delivering before 32,weeks of gestation reduced the risk ... Antenatal Magnesium Sulfate (BEAM) trial was,conducted in 18 centers ...
... Team Makes Crucial Breakthrough in Battle to Prevent ... Onset of Parkinson,s Disease, ... that scientists at The University of Nottingham,have made a crucial breakthrough ... common type of dementia and Parkinson,s disease., The researchers have ...
Cached Medicine Technology:National Study Shows Magnesium Sulfate Reduces Risk of Cerebral Palsy in Premature Births 2National Study Shows Magnesium Sulfate Reduces Risk of Cerebral Palsy in Premature Births 3The University of Nottingham in the British Midlands Announces Breakthrough in Parkinson's Disease Research 2
(Date:5/29/2015)... New York, NY (PRWEB) May 29, 2015 ... within USA Today, with a circulation of approximately 250,000 ... is distributed nationally, through a vast social media strategy, ... partner outlets. To explore the digital version of the ... the cover of the print publication. Inside, the actress, ...
(Date:5/29/2015)... The campaign focuses on the overall topic ... specific concerns within, including the importance of early intervention ... the workplace. We are encouraged to re-think the ways ... special focus to people living with bipolar disorder and ... help from healthcare professionals and their overall community. ...
(Date:5/29/2015)... 29, 2015 Healthpointe is now ... specialists, physical therapy, and injections , For patients ... and/or lower back pain, Healthpointe has a team ... herniated discs, disc protrusions and other causes of ... Healthpointe’s team of renowned surgeons are now treating ...
(Date:5/29/2015)... Dallas, Texas (PRWEB) May 29, 2015 ... a professional and in-depth study on the current ... figures the report provides key statistics on the ... source of guidance and direction for companies and ... a basic overview of the industry including definitions, ...
(Date:5/29/2015)... Florida (PRWEB) May 29, 2015 Designed ... Bodybuilding.com teamed up to create an all new, exclusive ... are a formulated with the latest and greatest, high ... and proven to be effective. The 24/7 Series can ... to cross-fitters and even the casual fitness enthusiasts. There ...
Breaking Medicine News(10 mins):Health News:Mediaplanet Brings Activism to Those Living with Mental Illness in Bew “Mental Health Awareness” Campaign 2Health News:Healthpointe’s Pain Management Specialists Now Providing Lumbar Epidural Injections in Los Angeles County 2Health News:Healthpointe’s Pain Management Specialists Now Providing Lumbar Epidural Injections in Los Angeles County 3Health News:Allopurinol Industry (Global, China) 2015 Research Analysis and 2020 Forecasts 2Health News:BPI Sports and Bodybuilding.com Partner Up to Bring an Innovative New Line of Supplements 2Health News:BPI Sports and Bodybuilding.com Partner Up to Bring an Innovative New Line of Supplements 3
... India has decided to prepare a set of guidelines ... standard quality (NSQ) medical devices, diagnostic reagents, diagnostic kits ... procedures to be followed and action to be taken ... ,Officials say the current move is to make ...
... Researchers from University of Texas Medical Branch at Galveston ... that may cause the allergic reactions// and asthma other ... ,This factor is the damage caused by chemically ... spawned by interactions between a single pollen-carried enzyme and ...
... common talk both in medical circles as well as social ... ,Therefore any news with respite from that is always welcome. ... linked to the insulin resistance syndrome among young obese adults. ... dairy intake may reduce the risk of type 2 diabetes ...
... have solved the structure of a critical piece of ... will help treat cardiac or neurological diseases//. ,Biologist Dale ... the structure of synapse-associated protein 97 (SAP97) found in ... www.brown.edu. ,This protein is believed to play a ...
... home can be of a grave nature and seems to ... ,Researchers at Cincinnati Children's Hospital Medical Center who had reported ... said that preventable injuries sustained at home account for more ... the results taken from the National Vital Statistics System Mortality ...
... Andhra Pradesh Chief Minister Y.S. Rajasekhara Reddy Saturday administered ... effort to create awareness on HIV/AIDS,. ,India has ... the highest prevalence of HIV cases in the country ... National AIDS Control Organization (NACO), the HIV prevalence rate ...
Cached Medicine News:Health News:Government Organisation Proposes Strict Guidelines For SubStandard Medical Devices 2Health News:New Insight Gained For Allergic Reactions 2Health News:"Defeat AIDS Pledge" by Andhra CM 2
4Fr, 5Fr & 6Fr diagnostic electrophysiology catheters with fixed curves....
... range of fixed curve catheters designed to ... and other patients with small anatomies. Each ... only the finest materials. A unique multi-step ... extrusion technologies results in the excellent torque ...
... To aid clinicians in performing Ankle/Brachial Index ... new, complete packet of information. It includes ... that can be viewed on any computer ... step-by-step procedure of performing an ABI test, ...
... VERICIS PhysioLog Hemodynamic Monitoring and Data ... system for the cath lab, integrating ... Waveform analysis , Data collection , ... Image capture/analysis , Procedural reporting ...
Medicine Products: